Inflammation and esophageal carcinogenesis

Area of Science:

• Gastroenterology
• Oncology
• Molecular Biology

Background:

• Esophageal adenocarcinoma incidence is rising, particularly in Western populations, with a poor patient prognosis.
• Gastroesophageal reflux disease and Barrett's esophagus are primary risk factors, linked to chronic esophageal inflammation (reflux esophagitis).
• The precise cellular mechanisms driving esophageal cancer development remain incompletely understood.

Purpose of the Study:

• To review the link between inflammation and esophageal carcinogenesis.
• To elucidate the molecular pathways involved in reflux-induced esophageal tumorigenesis.
• To highlight potential targets for novel therapeutic strategies.

Main Methods:

• Literature review focusing on inflammation's role in esophageal cancer.
• Analysis of molecular mechanisms including free radical generation, kinase pathways, and cytokine production.
• Examination of gene expression alterations related to proliferation and apoptosis.

Main Results:

• Chronic inflammation in Barrett's esophagus creates a pro-carcinogenic environment.
• Inflammatory cascades involve free radicals, activated signaling pathways, and inflammatory mediators.
• Altered gene expression in proliferation and apoptosis contributes to cancer development.

Conclusions:

• Reflux-induced inflammation is a significant driver of esophageal carcinogenesis.
• Understanding these molecular pathways is crucial for developing targeted esophageal cancer therapies.
• Further research into inflammation-associated tumorigenesis may improve treatment outcomes.